74 related articles for article (PubMed ID: 24594635)
21. Phenotypic and Molecular Characteristics of Children with Progressive Familial Intrahepatic Cholestasis in South China.
Zhang W; Lin R; Lu Z; Sheng H; Xu Y; Li X; Cheng J; Cai Y; Mao X; Liu L
Pediatr Gastroenterol Hepatol Nutr; 2020 Nov; 23(6):558-566. PubMed ID: 33215027
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of a Novel Missense Mutation in
Saleem K; Cui Q; Zaib T; Zhu S; Qin Q; Wang Y; Dam J; Ji W; Liu P; Jia X; Wu J; Bai J; Fu S; Sun W
Dis Markers; 2020; 2020():6292818. PubMed ID: 32626542
[TBL] [Abstract][Full Text] [Related]
23. Gene therapy for progressive familial intrahepatic cholestasis type 3 in a clinically relevant mouse model.
Weber ND; Odriozola L; Martínez-García J; Ferrer V; Douar A; Bénichou B; González-Aseguinolaza G; Smerdou C
Nat Commun; 2019 Dec; 10(1):5694. PubMed ID: 31836711
[TBL] [Abstract][Full Text] [Related]
24. A novel pathogenic variant of ATP-binding cassette subfamily B member 4 causing gallstones in a young adult.
Ishizawa T; Makino N; Kakizaki Y; Ando Y; Matsuda A; Kobayashi T; Ikeda C; Sugahara S; Tsunoda M; Sato H; Murakami R; Ueno Y
Clin J Gastroenterol; 2019 Dec; 12(6):637-641. PubMed ID: 31115781
[TBL] [Abstract][Full Text] [Related]
25. Novel compound heterozygote mutations of TJP2 in a Chinese child with progressive cholestatic liver disease.
Ge T; Zhang X; Xiao Y; Wang Y; Zhang T
BMC Med Genet; 2019 Jan; 20(1):18. PubMed ID: 30658709
[TBL] [Abstract][Full Text] [Related]
26. [Progressive familial intrahepatic cholestasis type 3].
Lipiński P; Jankowska I
Dev Period Med; 2018; 22(4):385-389. PubMed ID: 30636238
[TBL] [Abstract][Full Text] [Related]
27. Functional analysis of the correlation between ABCB11 gene mutation and primary intrahepatic stone.
Gan L; Pan S; Cui J; Bai J; Jiang P; He Y
Mol Med Rep; 2019 Jan; 19(1):195-204. PubMed ID: 30431138
[TBL] [Abstract][Full Text] [Related]
28. Phenotypic spectrum and diagnostic pitfalls of ABCB4 deficiency depending on age of onset.
Schatz SB; Jüngst C; Keitel-Anselmo V; Kubitz R; Becker C; Gerner P; Pfister ED; Goldschmidt I; Junge N; Wenning D; Gehring S; Arens S; Bretschneider D; Grothues D; Engelmann G; Lammert F; Baumann U
Hepatol Commun; 2018 May; 2(5):504-514. PubMed ID: 29761167
[TBL] [Abstract][Full Text] [Related]
29. Alterations in Intestinal Microbiota Lead to Production of Interleukin 17 by Intrahepatic γδ T-Cell Receptor-Positive Cells and Pathogenesis of Cholestatic Liver Disease.
Tedesco D; Thapa M; Chin CY; Ge Y; Gong M; Li J; Gumber S; Speck P; Elrod EJ; Burd EM; Kitchens WH; Magliocca JF; Adams AB; Weiss DS; Mohamadzadeh M; Grakoui A
Gastroenterology; 2018 Jun; 154(8):2178-2193. PubMed ID: 29454797
[TBL] [Abstract][Full Text] [Related]
30. Liver transplantation for decompensated liver cirrhosis caused by progressive familial intrahepatic cholestasis type 3: A case report.
Xiang D; He J; Wang H; Xiong F; Cheng H; Ai J; Shan R; Wan R; Zhang L; Shi J
Medicine (Baltimore); 2017 Dec; 96(50):e9158. PubMed ID: 29390323
[TBL] [Abstract][Full Text] [Related]
31. An expanded role for heterozygous mutations of ABCB4, ABCB11, ATP8B1, ABCC2 and TJP2 in intrahepatic cholestasis of pregnancy.
Dixon PH; Sambrotta M; Chambers J; Taylor-Harris P; Syngelaki A; Nicolaides K; Knisely AS; Thompson RJ; Williamson C
Sci Rep; 2017 Sep; 7(1):11823. PubMed ID: 28924228
[TBL] [Abstract][Full Text] [Related]
32. Embryonic cholecystitis and defective gallbladder contraction in the
Higashiyama H; Ozawa A; Sumitomo H; Uemura M; Fujino K; Igarashi H; Imaimatsu K; Tsunekawa N; Hirate Y; Kurohmaru M; Saijoh Y; Kanai-Azuma M; Kanai Y
Development; 2017 May; 144(10):1906-1917. PubMed ID: 28432216
[TBL] [Abstract][Full Text] [Related]
33. Current and future therapies for inherited cholestatic liver diseases.
van der Woerd WL; Houwen RH; van de Graaf SF
World J Gastroenterol; 2017 Feb; 23(5):763-775. PubMed ID: 28223721
[TBL] [Abstract][Full Text] [Related]
34. A Specially Designed Multi-Gene Panel Facilitates Genetic Diagnosis in Children with Intrahepatic Cholestasis: Simultaneous Test of Known Large Insertions/Deletions.
Wang NL; Lu YL; Zhang P; Zhang MH; Gong JY; Lu Y; Xie XB; Qiu YL; Yan YY; Wu BB; Wang JS
PLoS One; 2016; 11(10):e0164058. PubMed ID: 27706244
[TBL] [Abstract][Full Text] [Related]
35. Liver transplantation and the management of progressive familial intrahepatic cholestasis in children.
Mehl A; Bohorquez H; Serrano MS; Galliano G; Reichman TW
World J Transplant; 2016 Jun; 6(2):278-90. PubMed ID: 27358773
[TBL] [Abstract][Full Text] [Related]
36. Functional Rescue of Trafficking-Impaired ABCB4 Mutants by Chemical Chaperones.
Gordo-Gilart R; Andueza S; Hierro L; Jara P; Alvarez L
PLoS One; 2016; 11(2):e0150098. PubMed ID: 26900700
[TBL] [Abstract][Full Text] [Related]
37. MDR3 mutation analysis: A step closer to precision medicine.
Bezerra JA
Hepatology; 2016 May; 63(5):1421-3. PubMed ID: 26680260
[No Abstract] [Full Text] [Related]
38. ABCB4 mutations in adult patients with cholestatic liver disease: impact and phenotypic expression.
Degiorgio D; Crosignani A; Colombo C; Bordo D; Zuin M; Vassallo E; Syrén ML; Coviello DA; Battezzati PM
J Gastroenterol; 2016 Mar; 51(3):271-80. PubMed ID: 26324191
[TBL] [Abstract][Full Text] [Related]
39. Molecular mechanisms for biliary phospholipid and drug efflux mediated by ABCB4 and bile salts.
Morita SY; Terada T
Biomed Res Int; 2014; 2014():954781. PubMed ID: 25133187
[TBL] [Abstract][Full Text] [Related]
40. Functional analysis of ABCB4 mutations relates clinical outcomes of progressive familial intrahepatic cholestasis type 3 to the degree of MDR3 floppase activity.
Gordo-Gilart R; Andueza S; Hierro L; Martínez-Fernández P; D'Agostino D; Jara P; Alvarez L
Gut; 2015 Jan; 64(1):147-55. PubMed ID: 24594635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
